BillionToOne is trading 4.03% down at $106.21 after disclosure that CEO Oguzhan Atay sold 30,331 shares worth approximately $3 million on September 14, representing his entire directly held stake.
- The decline contrasts with the provided biotech-sector rally, while broader U.S. indexes are only modestly lower.
- The insider-sale disclosure appears to be the clearest catalyst, though available coverage does not explicitly quantify its impact on today’s trading.